Pursuant to regulation 36(1)(b) of SEBI (LODR) Regulations, 2015, the Company has dispatched letter containing weblink of Annual Report 2024-25
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aspira Pathlab & Diagnostics has informed the stock exchanges that it has dispatched letters containing the weblink to its Annual Report for FY2024-25 to shareholders who had not registered their email addresses with the company, depositories, or its registrar as of August 29, 2025. The 52nd Annual General Meeting of the company is scheduled for Friday, September 26, 2025, at 2:00 PM via Video Conferencing / OAVM. The full annual report is available on the company's website under the Investors section. This is a routine compliance filing under SEBI's listing regulations and does not involve any new financial or strategic information.
No material impact on the stock or shareholders – this is a standard procedural disclosure required for the upcoming AGM. Investors can access the FY25 annual report through the company's website to review full-year financials and governance details.